Biopharma Advances Demand Specialized Expertise

Publication
Article
BioPharm InternationalBioPharm International-06-15-2015
Volume 2015 eBook
Issue 1

Contract service providers share insights on biopharma market developments and the implications of biosimilar drug approvals.

 

The approval of the first biosimilar in the United States, as well as continuing consolidation in the biopharma and contract development and manufacturing markets, are just two indicators of the ongoing evolution of biopharmaceutical development. Representatives of contract service providers shared observations, trends and projections with BioPharm International.

 

Download

BioPharm International’s 2015 Outsourcing Resources eBook

.

 

 

 

 

 

 

Articles in this issue
BPsupp0615__QRM_200.jpg
QRM Tools for Contract Biomanufacturing
BPsupp0615_LangerFillFinish_200.jpg
Fill/Finish Trends
BPsupp0615_Feature_roundtable_200.jpg
Biopharma Advances Demand Specialized Expertise
BPsupp0615_IPLaw_200.jpg
Protecting Intellectual Property in Engagements with CMOs
BPsupp0615_Neostem_200.jpg
Taking a “Development-by-Design” Approach to Cell Therapies
Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Sanofi Invests €40 Million to Boost Antibody Production in France

Feliza Mirasol
November 21st 2024
Article

The investment will allow Sanofi to strengthen antibody bioproduction at its Lyon Gerland site in France.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

BioPharmaSpec Launches Three New R&D Facilities in Europe

Feliza Mirasol
November 20th 2024
Article

The new European facilities located in German, Italy, and Lithuania will specialize in drug discovery and R&D services.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics Gains $181.4 Million Funding to Advance Anti-Claudin-1 ADCs in Solid Tumors

Feliza Mirasol
November 18th 2024
Article

With financing led by OrbiMed, Novo Holdings, and Jeito Capital, Alentis Therapeutics will develop a pipeline of Claudin-1-targeted ADCs to treat solid tumors.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Frontier Scientific Solutions to use $1.5 Billion Funds to Establish Global Free Trade Zone Gateway for Life Sciences Supply Chain

Feliza Mirasol
November 15th 2024
Article

Empowered by a $1.5 billion commitment from a major investor, Frontier Scientific Solutions has unveiled its plans for establishing a global free trade zone gateway intended for facilitating the life sciences supply chain using Wilmington International Airport in North Carolina.

© 2024 MJH Life Sciences

All rights reserved.